M. Ikeda

566 total citations
19 papers, 410 citations indexed

About

M. Ikeda is a scholar working on Oncology, Epidemiology and Hepatology. According to data from OpenAlex, M. Ikeda has authored 19 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Epidemiology and 5 papers in Hepatology. Recurrent topics in M. Ikeda's work include Pancreatic and Hepatic Oncology Research (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). M. Ikeda is often cited by papers focused on Pancreatic and Hepatic Oncology Research (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). M. Ikeda collaborates with scholars based in Japan, United States and Czechia. M. Ikeda's co-authors include Hideki Ueno, Takuji Okusaka, Atsushi Hagihara, Chigusa Morizane, Shunsuke Kondo, Hiroshi Ishii, Satoru Iwasa, Tsutomu Tanaka, Noriya Hiraoka and Yuki Kojima and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

M. Ikeda

17 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Ikeda Japan 7 241 229 130 110 76 19 410
Takayoshi Fukutomi Japan 10 105 0.4× 195 0.9× 134 1.0× 73 0.7× 45 0.6× 19 362
F Latteri Italy 8 63 0.3× 107 0.5× 157 1.2× 18 0.2× 76 1.0× 24 301
Hirofumi Kanemura Japan 14 127 0.5× 120 0.5× 207 1.6× 9 0.1× 234 3.1× 24 533
Paula Kovarik United States 10 49 0.2× 84 0.4× 87 0.7× 13 0.1× 113 1.5× 21 324
Hiroaki Nagano Japan 11 106 0.4× 114 0.5× 188 1.4× 6 0.1× 133 1.8× 41 374
Morven Cunningham United Kingdom 10 74 0.3× 184 0.8× 222 1.7× 8 0.1× 55 0.7× 21 373
Jung Yeon Lee South Korea 12 63 0.3× 136 0.6× 9 0.1× 55 0.5× 130 1.7× 26 463
Ioana Rusu Romania 10 107 0.4× 96 0.4× 70 0.5× 6 0.1× 77 1.0× 48 282
F Meriggi Italy 10 130 0.5× 145 0.6× 321 2.5× 6 0.1× 241 3.2× 27 459
Akimichi Imamura Japan 9 130 0.5× 44 0.2× 37 0.3× 14 0.1× 91 1.2× 21 278

Countries citing papers authored by M. Ikeda

Since Specialization
Citations

This map shows the geographic impact of M. Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ikeda more than expected).

Fields of papers citing papers by M. Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ikeda. The network helps show where M. Ikeda may publish in the future.

Co-authorship network of co-authors of M. Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of M. Ikeda. A scholar is included among the top collaborators of M. Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Ikeda. M. Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Inoue, Katsumi, Taro Shibuki, Shun Yamaguchi, et al.. (2025). 369eP Impact of ascites on treatment outcomes of Nal-IRI+5-FU/LV in patients with pancreatic cancer with peritoneal dissemination. Annals of Oncology. 36. S143–S143. 1 indexed citations
2.
Ikeda, M., Satoshi Shimizu, Tosiya Sato, et al.. (2016). Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial. Annals of Oncology. 27(11). 2090–2096. 110 indexed citations
3.
Terashima, Takeshi, Chigusa Morizane, Nobuyoshi Hiraoka, et al.. (2012). Comparison of Chemotherapeutic Treatment Outcomes of Advanced Extrapulmonary Neuroendocrine Carcinomas and Advanced Small-Cell Lung Carcinoma. Neuroendocrinology. 96(4). 324–332. 44 indexed citations
4.
5.
Ohno, Izumi, Satoshi Shimizu, Hideaki Takahashi, et al.. (2011). Clinical significance of serum alkaline phosphatase level in advanced pancreatic cancer.. Journal of Clinical Oncology. 29(4_suppl). 183–183. 4 indexed citations
6.
Ikeda, M., S. Ohkawa, Akira Fukutomi, et al.. (2011). Randomized phase III study of gemcitabine plus S-1 (GS) versus S-1 versus gemcitabine (GEM) in unresectable advanced pancreatic cancer (PC) in Japan and Taiwan: GEST study.. Journal of Clinical Oncology. 29(15_suppl). 4007–4007. 33 indexed citations
7.
Iwasa, Satoru, Chigusa Morizane, Hideki Ueno, et al.. (2010). Cisplatin and Etoposide as First-line Chemotherapy for Poorly Differentiated Neuroendocrine Carcinoma of the Hepatobiliary Tract and Pancreas. Japanese Journal of Clinical Oncology. 40(4). 313–318. 126 indexed citations
8.
Furuse, J., M. Ikeda, Hiroshi Ishii, et al.. (2010). A Phase I/II Study of Combined Chemotherapy with Mitoxantrone and Uracil/Tegafur for Advanced Hepatocellular Carcinoma. Japanese Journal of Clinical Oncology. 41(3). 328–333. 1 indexed citations
9.
Ikeda, M., Yoshiro Ito, Naohiro Yonemoto, et al.. (2010). A multicenter phase II trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer.. Journal of Clinical Oncology. 28(15_suppl). 4058–4058. 2 indexed citations
10.
Ikeda, M., Takuji Okusaka, Hideki Ueno, et al.. (2006). A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer. Journal of Clinical Oncology. 24(18_suppl). 14003–14003.
11.
Ueno, Hiroyuki, Takuji Okusaka, M. Ikeda, et al.. (2004). Phase I study of gemcitabine and S-1 combination therapy in patients with advanced pancreatic cancer. Journal of Clinical Oncology. 22(14_suppl). 4160–4160. 1 indexed citations
12.
Takezako, Yoriko, et al.. (2004). [Tumor markers for pancreatic and biliary tract cancer].. PubMed. 31(9). 1443–6. 5 indexed citations
13.
Okusaka, Takuji, Yoshikazu Kagami, Hideki Ueno, et al.. (2003). Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer. International Journal of Radiation Oncology*Biology*Physics. 57(2). S383–S384. 1 indexed citations
14.
Okada, Shuichi, et al.. (2000). The Usefulness of Serial Changes in Serum CA19-9 Levels in the Diagnosis of Pancreatic Cancer. Pancreas. 20(4). 378–381. 20 indexed citations
15.
Yamada, Takafumi, Hiroyuki Ohta, Tatsuru Masuda, et al.. (1998). Purification of a Novel Type of SDS-Dependent Protease in Maize Using a Monoclonal Antibody. Plant and Cell Physiology. 39(1). 106–114. 20 indexed citations
16.
Nagahama, Hiroyasu, Shoichi Okada, Takuji Okusaka, et al.. (1997). Predictive Factors for Tumor Response to Systemic Chemotherapy in Patients With Hepatocellular Carcinoma. Japanese Journal of Clinical Oncology. 27(5). 321–324. 30 indexed citations
17.
Akiyama, Hisako, Akihiko Kanamoto, Yasuhiro Abe, et al.. (1989). [Outburst of fusidic acid resistant Staphylococcus aureus].. PubMed. 99(4). 507–10. 4 indexed citations
18.
Yamase, Osamu, et al.. (1988). Industrialization of a New Steelmaking Process Utilizing Hot Metal Pretreatment and Smelting Reduction. Tetsu-to-Hagane. 74(2). 270–277. 2 indexed citations
19.
Orimo, Satoshi, et al.. (1987). A case of “myopathy with tubular aggregates” with increased muscle fibre sensitivity to caffeine. Journal of Neurology. 234(6). 424–426. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takayoshi Fukutomi Breakdown of academic impact, for papers by F Latteri Breakdown of academic impact, for papers by Hirofumi Kanemura Breakdown of academic impact, for papers by Paula Kovarik Breakdown of academic impact, for papers by Hiroaki Nagano Breakdown of academic impact, for papers by Morven Cunningham Breakdown of academic impact, for papers by Jung Yeon Lee Breakdown of academic impact, for papers by Ioana Rusu Breakdown of academic impact, for papers by F Meriggi Breakdown of academic impact, for papers by Akimichi Imamura
Rankless by CCL
2026